Capstone Deep Dive: US

Phase 10 · Weeks 75–76 · ~40 hours (2 weeks) · CAPSTONE: half of the M11 final gate · Mastery gate ≥85%

Where it sits. Two weeks, one US company you have never studied, and nothing to lean on. This is the first of the two independent capstone deep dives that stand between you and the program's final competency audit. Everything before Phase 10 built and certified the parts: Phase 1 taught you to read a filing, Phase 2 to trust or distrust it, Phase 3 to value it three ways, Phases 4–5 to judge the business and its industry, Phases 6–7 to supply temperament and macro context, Phase 8 to compress all of it into the two-hour and three-day formats and certify that the signature skill is real, and Phase 9 to size, hold, and sell what the skill finds. M8.05 proved the engine runs, under a stopwatch, on never-studied companies, at the rubric bar. What comes off now is the last scaffold that certification still left in place: the permission to be merely competent. In M8.05 you cleared a pass bar. Here you produce an institutional-grade thesis package on a US company you have never studied, unaided, over two weeks, held to the standard a portfolio manager would apply before risking capital or a research director before publishing your name. It is the same deep dive you certified in Phase 8, run at higher stakes, greater depth, and a higher bar, and it is where all eleven competencies finally converge into a single work product. M10.02 does the same on an Indian company (adding the promoter/governance layer); M10.03 polishes the communication; M10.04 audits you against the Section 1 competency map and closes the program. Pass this and M10.02 at the institutional rubric, and you have demonstrably done, twice and alone, the thing the entire program was backward-designed to make you able to do.

Suggested hour budget (across two weeks; the day-by-day plan is §4.4). Reading the standard, the candidate list, the deliverable spec and the self-review protocol, and, above all, studying the fully-worked walkthrough (§6) until you can see the finished standard clearly: ~5h. The capstone deliverable itself: ~30h spread across ten working days (history and incremental ROIC ~6h; industry map, moat dossier, and peer benchmark ~5h; the three-way valuation ~6h; incentives, scuttlebutt, and the earnings-call audit ~6h; the steelman, one-page thesis, and pre-mortem ~4h; assembling and self-reviewing the package ~3h). Practice set, mastery-check readiness, flashcards, and the journal: ~5h. The deliverable is the module; budget accordingly, and protect the depth. A capstone rushed into a weekend is not a capstone.

App link. This is the capstone tier of the Rapid-Analysis System branch. The app's "analyze this business" case engine serves you a never-studied US company's real-filing snapshot (drawn from the SEC EDGAR company-facts data bundled at build time), hosts each deliverable (the ten-year history grid, the incremental-ROIC calculator, the reverse-DCF decoder, the moat-classification panel), and rubric-scores the one-page thesis and pre-mortem against the institutional rubric (§8). Your per-criterion scores feed the mastery heatmap. The calibration dashboard logs your confidence and re-check date so that months later, when reality grades your variant view, the app can score your reasoning: the process-over-outcome discipline (working-agreement 8) that separates a mechanically-competent analyst from a calibrated one. After you pass, the spaced-skill scheduler keeps the capstone-grade deep dive in rotation so the standard never quietly decays.

Learning objectives

By the end you can:

1. Execute the entire program's system, unaided, on a US company you have never studied, going from a blank spreadsheet and a set of primary filings to a complete, institutional-grade thesis package, with no worked trail, no template prompting, and no AI, drawing only on the certified skill and the reusable artifacts you keep on your desk forever.
2. State precisely what "institutional-grade" means and hold your own output to it: not "clears the certification bar" but "would survive a hostile portfolio manager's read-through and could be published under your name": every claim sourced, every number tied to a filing, every qualitative judgment turned into a countable metric, and the whole thing conclusion-first.
3. Select the right capstone target from an approved candidate list: a company whose accounting is clean enough to learn on, whose disclosure is rich enough to work with, and whose price embeds a genuine, judgeable question. Then confirm honestly that you have never studied it.
4. Produce every component of the required thesis package to the deliverable spec: the ten-year spreadsheet history with incremental ROIC; the industry map (five forces + profit pool + share-stability test); the four-lens moat verdict proven in the numbers; the three-way valuation (DCF + comps + reverse DCF) triangulated to a defensible range; the management, capital-allocation, and incentives read from the DEF 14A; the scuttlebutt findings; the steelmanned bear; the one-page thesis; and the pre-mortem wired to a monitoring dashboard.
5. Triangulate a three-way valuation into an honest range whose width is itself information, reconciling what the DCF says the business is worth, what comparable multiples imply, and what the current price is already assuming (reverse DCF), then convert the gap between them into a falsifiable variant perception.
6. Grade your own package against the institutional rubric like a hostile examiner: scoring each deliverable component 0/1/2 against printed anchors, reading the total as a map of what to strengthen rather than a verdict on your worth, and catching the specific capstone failure modes (the book report, the false-precision valuation, the un-steelmanned bear, the missing variant question) before a grader does.
7. Run the two-week capstone as a project: sequencing the ten working days so that the numbers precede the narrative, the valuation is built on a rebuilt history rather than a screener export, and the qualitative edge (scuttlebutt, incentives, candor) is gathered after the numbers have told you what to look for.

Prerequisites & connections

Builds on: essentially the whole program, put to work at once. There is almost no new technique here; the entire content is the unaided synthesis of everything, held to a professional standard. Most immediately it rests on Phase 8: the source stack and 45–60-minute filing skim (M8.01), the twelve teardown questions and eight-line output (M8.02), the ten-year history and incremental ROIC (M8.03), the reverse DCF (M8.03), and the scuttlebutt, DEF 14A incentive read, steelman, one-page thesis, and pre-mortem (M8.04), all certified in M8.05. It leans just as hard on the machinery those modules assume: the three-statement linkage (M1.05) and full filing anatomy (M1.10); NOPAT, invested capital, and incremental ROIC by hand (M2.03), FCF and cash conversion (M2.04), the quality-of-earnings reflexes and red-flags checklist (M2.06–2.08); the WACC build (M3.03), FCFF forecasting and terminal value (M3.04–3.05), relative valuation and the driver algebra behind each multiple (M3.06), value drivers and the g = reinvestment rate × ROIC discipline and the five uses of capital (M3.07), and the three-statement model (M3.08–3.09); the four-lens moat protocol and share-stability test (M4.04–4.05); the sector KPI panels (Phase 5); the mental-model and personal checklists (M6.05); the macro overlay (Phase 7); and the sizing/sell/journal discipline (Phase 9). The reusable artifacts are your working kit: the 2–3 day deep-dive workbook, the 45–60-minute statement-read checklist, the red-flags / quality-of-earnings checklist, the valuation workflow, the sector KPI cheat-sheets, the mental-model & moat checklist, and the macro dashboard.

Feeds forward. M10.02 is the same work run again on an Indian company: the same institutional standard plus the promoter-holding, pledge, related-party, and Ind AS layer that a US name does not exercise. M10.03 (the communication toolkit) takes the thesis package you produce here and teaches you to present it Minto-style, conclusion first, MECE grouping, clean exhibits. Hold on to your draft; it becomes M10.03's raw material. M10.04 re-grades your week-3 sealed one-pagers against what you can now do, and runs the final competency audit: both capstone theses (this one and M10.02's) must pass the institutional rubric for the M11 gate, which is core professional competence, all eleven competencies at bar. Competency C10 (the signature skill) is exercised here at its highest level; C3, C4, C5, C7, C9, and C11 all converge in the single deliverable; and the package you produce is the first entry in the public track record M10.04 has you build.

The one-sentence version. You have certified that the engine runs. Now drive it alone, on unfamiliar roads, to a professional standard, and produce a thesis package good enough to put your name on.

Core teaching content

4.1 What a capstone is, and what "unaided, institutional-grade" means

A capstone is not a lesson; it is a demonstration. There is nothing new to learn here. If there were, it would belong in an earlier phase. What is new is the absence of everything that has helped you until now: no worked example runs beside you (the walkthrough in §6 is a finished standard to study before you start, not a trail to follow during your own company); no template prompts you question by question; no module tells you which sector lens to reach for or which normalization the history needs; and, per the program's founding constraint, no AI drafts, summarizes, or checks a single line. You are handed a company and a fortnight, and you produce the work. That absence is the point: a skill you can only perform with scaffolding is not yet yours, and the capstone is the assay that proves it is.

The standard is the harder half of the definition. Institutional-grade is a specific, demanding thing, and it is worth stating in full because most of the difference between a certification-passing deep dive and a capstone-passing one lives here:

• Every number is traceable to a primary filing. Not a screener's computed ROIC but your ROIC, built from the 10-K's operating income, tax note, and balance sheet, with the normalizations logged. A grader can pick any figure in your package and you can show the filing line it came from. Screener exports are for speed and cross-check, never for the number you stake a claim on (working-agreement 7).
• Every qualitative claim is turned into a number (Damodaran's narrative-and-numbers discipline). "Wide moat" is not a claim; "operating ROIC of 30–50% sustained across two full cycles, gross margin stable at 60–69%, and share stable within two points over a decade" is a claim. "Great management" is not a claim; "returned 100% of free cash flow for fifteen years and reduced share count 46% while raising the dividend twenty-one consecutive years" is a claim. The package contains no adjective that is not backed by a metric.
• The valuation is a range, and the range is defended, not decorated. Three methods, triangulated; a base, a bull, and a bear that fall out of stated assumption changes, not mood; and an honest width, because the width of a defensible range is information about how hard the business is to value (a tell you understand it, not a failure to be precise).
• The bear case is argued better than the bears argue it, then answered. An institutional thesis that has not steelmanned its own antithesis is not a thesis; it is advocacy. The single most valuable hour of the two weeks is the one where you build the short case stronger than its authors and then decide whether your variant view survives it.
• There is a falsifiable variant perception. The package does not merely describe a company well; it says what the market appears to have wrong and why you might be right, in one sentence that reality can later prove false. No variant perception means no edge means no reason for the work to exist.
• It is conclusion-first and clean (Minto; C11). A PM reads the one-page thesis first and can find the support for any claim in seconds. Exhibits are legible, sourced, and dated. A thesis a reader cannot navigate is not institutional-grade however correct it is.

Hold those six standards in mind as the definition of the bar. The rubric in §8 operationalizes them criterion by criterion; the walkthrough in §6 shows them met on a real company; and the self-review protocol in §4.5 is how you check your own package against them before a grader does.

How this differs from the M8.05 certification (so you calibrate the effort). The certification deep dive proved the skill is real in ~10 hours at the ≥26/32 bar. The capstone proves the skill is professional in ~30 hours at a higher bar and greater depth: a full three-way valuation rather than a reverse DCF plus a rough model; a real scuttlebutt effort across multiple channels rather than a thin pass; four-to-eight earnings calls actually audited with a promise ledger rather than one or two sampled; a moat dossier that runs all four lenses explicitly rather than naming a source; and a package (a set of durable, navigable artifacts a third party could read) rather than a filled workbook. Certification is a driving test; the capstone is driving a real route, alone, with a passenger who will judge the ride.

4.2 The approved US candidate list

Choose one company from the list below that you have never studied: not in a module, not as a company-of-the-week, not in the app. (If you have already torn one down, it is disqualified for you; that is what the alternate set in the Mastery check, §11, is for.) The list is curated so that every name satisfies the three things a capstone target needs: clean-enough accounting to learn on (no name here requires forensic archaeology just to trust the numbers; that is M10.02's Indian-governance job and the Phase 2 forensic cases' job, not the capstone's); rich-enough disclosure to work with (all file full 10-Ks and DEF 14As on EDGAR, hold earnings calls, and have peers to benchmark against); and, most importantly, a price that embeds a real, judgeable question, because a company whose valuation is obviously right or obviously wrong teaches you nothing about the variant-perception muscle that is the heart of the deliverable.

The list spans the archetypes deliberately, so that whichever you pick, you exercise a different edge of the skill. Pick one whose sector you are weaker in if you want the hardest honest test; pick one whose archetype most interests you if you want the work to sustain two weeks of attention. Every company is a teaching specimen, not a recommendation; statuses, structures, and prices change, so confirm the current picture before relying on any framing (as of mid-2026).

If none of these is genuinely novel to you (you have studied more than a fortnight's worth of them by now), draw from the Form B alternate set in §11, or pull a fresh US large-cap off a screener and confirm it meets the three criteria above: clean accounting, rich disclosure, a live valuation question. The integrity rule from M8.05 governs: the capstone's entire value is that the company is genuinely unfamiliar. A name you secretly half-know certifies nothing.

4.3 The deliverable: the institutional thesis package

The output of this module is a thesis package: a set of nine durable, navigable, dated artifacts that together answer the five questions at institutional depth and hand a reader a decision. It is the deep-dive workbook filled to a professional standard, plus a genuine three-way valuation, assembled into something a third party could read cold and understand. Produce every component; the rubric (§8) scores each, and several may not score zero. Stamp the price and data dates on the cover. A thesis is perishable.

1. The ten-year spreadsheet history + incremental ROIC. Built by hand from the filings (not imported), one column per fiscal year, the standard rows: revenue total and by segment; growth (volume vs price where disclosed); the margin stack (gross, EBIT, net); NOPAT; invested capital; ROIC/ROCE; CFO, capex, FCF; CFO/EBITDA and FCF/PAT; net debt and net debt/EBITDA; working-capital days; diluted share count; dividends + buybacks, with every normalization logged (segment restatements, one-offs, acquisitions, accounting-standard breaks). Then incremental ROIC (ΔNOPAT ÷ Δinvested capital) over rolling multi-year windows, interpreted as the true compounder test, with explicit handling of any lag between capital spent and profit earned. This is where you decide question 2 (is it a good business), and it is not delegable to a screener.

2. The industry map. Mauboussin's supplier→firm→customer value chain with the profit pool located (where in the chain the profits actually sit, and whether this firm sits there); Porter's five forces, each rated with one line of evidence; and the market-share-stability test (share moving >~2%/yr signals a weak moat) against the incumbents. The map places the business in its competitive structure and sets up the moat verdict.

3. The four-lens moat verdict, proven in the numbers. All four lenses, run explicitly: Dorsey's five sources (intangibles/brand, switching costs, network effects, cost advantages, efficient scale, and which do not apply); Greenwald (collapse the forces to barriers to entry; the share-stability confirmation); Helmer's 7 Powers (each as Benefit + Barrier); and Mauboussin (persistent ROIC > WACC, the Competitive Advantage Period, resistance to mean reversion). State the verdict: moat present or not, source, width, and direction (widening/stable/eroding). It is confirmed in the ROIC series, gross-margin stability, and share table, never asserted in adjectives. Reject false moats (hot product, hot management, high share, good execution) explicitly.

4. The three-way valuation → a defensible range. All three, triangulated: a DCF (FCFF forecast tied to the rebuilt history, WACC built from scratch, terminal value with g ≤ economy growth and terminal ROIC → WACC discipline, base/bull/bear from stated assumption changes); relative valuation (the right multiples for the sector, comps chosen and normalized, the driver algebra behind each); and a reverse DCF (hold the rate, solve for the growth/margin/duration the current price implies, and judge it against base rates and your moat evidence). Reconcile the three into a single range with a stated midpoint and an honest width, and convert the gap between price and value into the variant perception.

5. The management, capital-allocation & incentives read (from the DEF 14A). The five uses of capital over a decade (reinvest, M&A, dividends, buybacks, debt paydown) read off the history and judged on incremental returns; the proxy dissected for the metrics behind bonus and long-term incentive pay, executive ownership (skin vs salary), and any related-party items; and a predicted allocation bias from the incentive structure (EPS/size metrics → buyback-at-any-price and empire-building; ROIC/economic-profit metrics with a growth gate → discipline), checked against the actual ten-year record. The verdict: are these good, honest, aligned capital allocators?

6. The scuttlebutt findings. Fisher's method via free modern channels: customer signal (product reviews, forums, distributor availability), competitor commentary (rivals' calls and decks as an expert-network substitute), culture and retention (Glassdoor trend and text), and at least one real channel check (a store/branch visit, an app-store read, a web-traffic or headcount alt-data pull). Triangulate these into a mosaic, note each source's built-in bias, and confine yourself to non-material public facts. Mark which of Fisher's fifteen points the numbers already answered and spend the field time on culture, candor, and the industry-peculiar tell.

7. The earnings-call audit + steelman-the-bear. Four-to-eight earnings calls read across good and bad quarters, scored on the four tells (do they answer the question asked; own mistakes specifically; match prior promises; keep a consistent story) with a promise ledger; and the bear case rebuilt stronger than its authors from short reports (read for method, not verdict), the 10-K risk factors, and independent bears, each point classified as a valuation-bear or a thesis-bear, and then answered. The single strongest thesis-level bear point is named.

8. The one-page thesis. The deliverable that fits on one page and that a PM reads first: the business (what it does, the real profit engine); why it is a good business (moat source + ROIC-persistence proof + direction; management/incentive verdict); the variant perception (what the price implies vs what you believe, and why you might be right when the market is wrong, in one falsifiable sentence); the three things that must go right (falsifiable); valuation & expected return (the base/bull/bear range, margin of safety, what you'd pay); and sell criteria (written now, before ownership). All five spine questions must be answerable from this page.

9. The pre-mortem → monitoring dashboard. "It is three years later and this was a disaster — what happened?" The answer is a set of specific, company-level failure paths (not "the market fell"), ranked by probability × severity, each wired to a measurable early-warning trigger. Those triggers are the monitoring dashboard and map one-to-one onto the sell criteria. The pre-mortem is what converts a hopeful story into a falsifiable, monitorable thesis.

The nine components are not nine essays; they are one integrated argument. The history decides whether it is a good business; the industry map and moat dossier explain why the returns persist or won't; the incentives read judges the stewards of the cash those returns throw off; the scuttlebutt and call audit stress-test the qualitative claims the numbers can't see; the valuation prices it; the steelman and pre-mortem attack it; and the one-page thesis distils all of it into a decision with a falsifiable variant view. A package where the valuation does not rest on the rebuilt history, or the moat verdict does not survive the steelman, or the one-page thesis contains a claim the body does not support, is not integrated. Integration is a large part of what "institutional-grade" means.

4.4 The two-week time budget: a ten-day project plan

Forty hours across two weeks is enough time to do this well and not enough to do it lazily; the failure mode is not too little time but poor sequencing: starting the valuation before the history is rebuilt, or gathering scuttlebutt before the numbers have told you what to ask. The governing discipline is the same one that defeats anchoring in a timed teardown, scaled up to a fortnight: the numbers come before the narrative, and the qualitative edge comes after the numbers have posed the question. Here is the default plan; bend it to the company (a bank spends more days on asset quality and less on unit economics), but keep the order.

Two features of this plan do most of the work. First, the valuation (days 6–7) sits after the history, industry, and moat (days 2–5), so that your forecast assumptions are disciplined by a decade of rebuilt evidence rather than by a screener's consensus, and your reverse DCF is judged against a moat verdict you have actually earned. Second, the qualitative edge (days 8–9) comes after the valuation, because the reverse DCF's implied story is exactly what your scuttlebutt and call audit should be trying to confirm or break; gathering scuttlebutt before you know the variant question is tourism, not research. The final half-day of self-review is not optional polish; it is where a good package becomes an institutional one (§4.5).

4.5 The self-review protocol: grade your own package honestly

You will submit this to yourself (and, in the app, to the rubric grader), which means the honesty of your self-review is the quality control. The protocol has three passes, run in order on the finished package before you call it done.

Pass 1 — the rubric pass (mechanical). Open the institutional rubric (§8) and score each of the ~18 criteria 0/1/2 against its printed anchor, exactly as a grader would, writing the score and a one-line justification beside each. Total it. Check the hard gates (the criteria that may not score 0 or 1). This pass is deliberately mechanical and unsentimental: a criterion either meets its anchor or it does not, regardless of how much of the two weeks it consumed. Effort is not a criterion.

Pass 2 — the hostile-PM read-through (holistic). Now read the one-page thesis first, as a skeptical portfolio manager would, and then go looking in the body for the support of every claim on that page. Three questions: (a) Can I find the evidence for every assertion within seconds, and is it sourced to a filing? If a claim on the one-pager has no support in the body, it is either cut or supported. (b) Is there a genuine variant perception, or have I just described a company well? If you cannot state, in one falsifiable sentence, what the market has wrong and why you might be right, you have written a book report, and the fix is to return to the reverse DCF and find the disagreement. (c) Would I risk capital on this, and if not, what is missing? The honest answer often reveals that the bear was not truly steelmanned or the pre-mortem was generic.

Pass 3 — the calibration entry (for later). Log, in the decision journal, your confidence in the variant view (as a probability), the two or three things that would change your mind (the break-variables, with thresholds), and a re-check date. This pass produces nothing the rubric scores today; it is the hook on which outcome feedback hangs months from now, when reality grades your reasoning (process over outcome, working-agreement 8). A capstone without a calibration entry is a capstone you can never learn from.

The self-review's whole value is that it is adversarial. A generous self-grade ("I basically covered the moat") is a loan from your future self, repaid with interest at the M11 final audit or, worse, when real capital is on the line and the skill you certified generously was not actually there. Grade against the anchor, read the total as a map of what to strengthen (not a verdict on you), fix the three weakest components in the final half-day, and only then call the package done.

Common mistakes & how experts think differently

These are the failure modes specific to the capstone: the ways a competent, certified analyst produces a package that falls short of institutional-grade. They are different from the timed-teardown failures of M8.05 (rabbit-holing, anchoring, false precision under a clock); a capstone has two weeks and no stopwatch, so its failures are failures of standard, not of speed. Read them before you start, and check your finished package against them in the self-review.

1. The book report — description without a variant view. The most common capstone failure by far: two weeks produce a beautiful, thorough, correct description of a company (history rebuilt, moat mapped, valuation modeled) and no falsifiable claim about what the market has wrong. It reads like a well-made Wikipedia entry with a valuation appendix. The expert knows a thesis is defined by its variant perception: the one-sentence, falsifiable statement of what you believe that the price does not. A package without it has no reason to exist, because if your view is the consensus, there is no edge and no decision. The fix is mechanical: the reverse DCF tells you exactly what the market believes; your job is to find where the evidence you rebuilt supports a different belief. If you cannot, the honest output is "no variant view — pass," which is itself a professional conclusion (and far better than manufacturing a fake disagreement).

2. The screener-import history. Importing the ten-year numbers from stockanalysis.com or TIKR and building the valuation on top of them, skipping the by-hand rebuild. It looks identical to the real thing and is worth a fraction of it, because you learn the business by typing its history: the year the segment was re-defined, the tax-rate break, the acquisition that inflated goodwill, the lease-standard change that moved EBITDA. A clean screener export shows you none of that, and all of it decides whether the series is comparable and the ROIC is real. The expert rebuilds by hand once and cross-checks against the screener; the novice imports the screener and calls it a rebuild. The rubric's history criterion is written to catch exactly this: "tied to filings," not "tied to a data vendor."

3. The un-steelmanned bear. Stating the bear case weakly, as a strawman easily knocked down, so that the variant view survives by default. This is advocacy wearing the costume of analysis. The expert spends the single most valuable hour of the two weeks building the short case stronger than the shorts build it, from real short reports and the risk factors, and only then decides whether the thesis survives. Often it does not survive intact, and the thesis gets weaker, narrower, and more honest, which is the steelman working. A capstone whose bear section is three sentences of "of course there are risks, but…" has skipped the part that makes it institutional.

4. The false-precision valuation — or the false-range one. Two opposite errors. The first: a single-point "fair value $187.40" that projects a confidence the inputs cannot support. The second, subtler and more common at this level: a base/bull/bear "range" whose three legs are decoration: the same model nudged up and down by a few percent, so the "range" is $180–$200 and pretends the business is easy to value when it is not. The expert's range falls out of genuinely different assumptions (does the reinvestment earn 30% or 9%? does the moat's CAP run ten years or twenty?), so its width is honest information about the business's difficulty. A suspiciously narrow range on a hard-to-value company is a tell that the assumptions were not truly varied.

5. Valuation divorced from the history and moat. Building a DCF whose growth and margin assumptions come from consensus or optimism rather than from the decade you just rebuilt and the moat you just judged. The tell: a forecast that assumes margins expand while the moat verdict was "eroding," or reinvestment at high returns while incremental ROIC was falling. The expert's valuation is downstream of the history and moat: the assumptions are disciplined by the evidence, g = reinvestment × ROIC holds every year, and the terminal ROIC is consistent with the moat's durability. Integration is the standard: the nine components are one argument, not nine.

6. Skipping the incentive read, or reading it as box-ticking. Glancing at the DEF 14A, noting "pay is performance-linked," and moving on. The expert reads the proxy for the specific metrics that drive the bonus and long-term incentive, because "show me the incentive and I'll show you the outcome": a management paid on EPS growth will buy back stock at any price and chase dilutive acquisitions; one paid on ROIC or economic profit with a growth gate will allocate with discipline. The read produces a prediction of capital-allocation behavior, which you then check against the ten-year record. Agreement (or disagreement) between the incentive and the record is itself a finding.

7. Scuttlebutt as an afterthought — or as an excuse for tourism. Two failures: gathering no primary qualitative signal at all (a package built entirely from filings), or gathering it before the numbers have posed the question (reading Glassdoor and app reviews with no idea what you are looking for). The expert does scuttlebutt last among the inputs, after the reverse DCF has named the variant question, and aims every channel at confirming or breaking that specific question. Is the moat's captivity real (dealer/customer checks)? Is the culture consistent with the reinvestment claim? Triangulate a mosaic and note each source's built-in bias. Directed scuttlebutt is research; undirected scuttlebutt is procrastination.

8. Confusing length with depth. A ninety-page package feels rigorous and can still be thin where it counts: a gorgeous history and a perfunctory pre-mortem. The expert judges the package by whether the five load-bearing components are strong (incremental ROIC, the reverse DCF, the steelman, the one-page thesis, the pre-mortem), not by page count, and would rather submit thirty tight pages where those five are excellent than ninety where the history is beautiful and the thesis is vague. The rubric weights those five precisely because they are where a long analysis either earns its length or reveals itself as activity.

9. No pre-mortem teeth — the generic disaster. A pre-mortem that says "the economy could weaken and the stock could fall" has done nothing, because it is not company-specific and not measurable. The expert writes specific, company-level failure paths ("the 300mm fabs run at 50% utilization through 2028 because the demand recovery doesn't come, depreciation crushes margins, and the FCF/share recovery the price assumes never arrives") and wires each to a countable early-warning trigger (utilization disclosed on the call; gross-margin trajectory; FCF/share vs the stated aspiration). Those triggers become the monitoring dashboard and the sell criteria. A pre-mortem you cannot monitor is a worry, not an instrument.

The unifying difference between the competent and the institutional: the competent analyst produces correct components; the institutional analyst produces an integrated, falsifiable, self-attacked argument that ends in a decision, and holds every claim to a filing and every judgment to a number. The rubric (§8) is that difference made explicit; the walkthrough (§6) is it made concrete.

Worked examples

Texas Instruments' free cash flow collapsed from ~$6bn to ~$1.5bn in two years, and the stock still trades at ~36× trough earnings. What follows is an institutional-grade capstone package on Texas Instruments (TXN, US), carried through every one of the nine deliverable components so you can see the finished standard before you produce your own. Study it not to copy its conclusions, since your company will be different, but to internalize the shape of institutional-grade work: how the history disciplines the valuation, how the moat verdict is proven rather than asserted, how the three valuation methods triangulate to a range, how the incentive read produces a prediction, and how the whole thing resolves into a falsifiable variant perception and a monitorable pre-mortem.

Texas Instruments is chosen because it is, as of mid-2026, a genuinely live institutional debate of exactly the right shape: an unambiguously wonderful business (decades of high ROIC, a real moat, the most disciplined capital-allocation doctrine in US large-cap) that is simultaneously in the middle of the biggest capital-spending program in its history, a multi-year build of 300mm wafer fabs that has crushed near-term free cash flow and collapsed the free-cash-flow-per-share metric the company itself preaches. A great business, a depressed cash metric, and a price that must be assuming a recovery: that combination is the ideal specimen for a capstone, because the whole question is the one where edge lives: is the reinvestment value-creating, and is the price paying too much or too little for a recovery that hasn't happened yet? A company whose valuation were obviously right would teach nothing.

All figures below are illustrative, round approximations modeled on ~FY24/FY25 scale. Pull the actual 10-K and DEF 14A from EDGAR and recompute as your own drill. Texas Instruments is a teaching specimen, not a recommendation; every valuation is a range; and the walkthrough is evenhanded by construction: the bear is argued at full strength before the thesis answers it.

6.0 Setup: the frame and the source stack (Day 1)

Source stack assembled first (this time is not part of any clock — the capstone has no stopwatch): ten years of 10-Ks (FY15→FY24, read oldest→newest); the latest DEF 14A; the last eight earnings-call transcripts (spanning the FY22 peak, the FY23–24 downturn, and the capex ramp); TI's own long-running "Capital Management" investor materials (the FCF-per-share doctrine, laid out explicitly for over a decade, a gift for the incentive read); one competitor's materials (Analog Devices' latest 10-K and call, as the cleanest analog peer); and one bear note (a sell-side skeptic on the capex program). The ten-year panel is cross-checked against stockanalysis.com but rebuilt by hand from the filings.

The provisional variant question, framed on Day 1 (to be resolved by the work): the market has de-rated TXN's cash metrics (FCF and FCF/share) hard because of the fab build, yet holds the multiple high (~36× trough earnings). So the price is implicitly saying "look through the capex trough to a large, on-time free-cash-flow recovery." The question the two weeks must answer: is that implied recovery a conservative bet, a fair bet, or an optimistic one, and is the reinvestment that causes the trough actually value-creating? Everything below serves that question.

6.1 Component 1: the ten-year history + incremental ROIC

The rebuilt panel (illustrative; six representative years shown, but built for all ten). Every figure traces to the income statement, cash-flow statement, and balance sheet of the corresponding 10-K; normalizations are logged below.

Normalizations logged: the ~13% effective tax rate reflects the post-2018 US regime and R&D/manufacturing credits (pre-2018 years re-stated to a comparable operating basis); goodwill (~$4.4bn, from the 2011 National Semiconductor acquisition) is constant and included in invested capital; FY23–24 invested capital rises steeply as fab construction-in-progress capitalizes into PP&E ahead of producing revenue; no segment re-definitions distort the Analog/Embedded split over the window.

Reading the panel as a story (not a snapshot). Three arcs jump out. (1) The historical machine is elite. Through FY22, ROIC ran 30→48%, gross margin 58→69%, and FCF/share compounded from ~$3 to ~$6.8: a capital-light analog compounder throwing off cash, most of it returned (share count down from 1,048m to 918m). This is the shape of a great business the M8.05 Difficulty-1 reps teach you to recognize. (2) FY23–24 is a double hit: a cyclical revenue decline (−12%, −11%, as auto and industrial customers destocked) and a deliberate capex surge (capex from ~$2.8bn to ~$5bn+), so margins compressed (utilization fell, new-fab depreciation began) and FCF collapsed from ~$6bn to ~$1.5bn, dragging FCF/PAT to an alarming-looking 0.31. (3) The critical judgment: that collapsed FCF/PAT is not a quality red flag. It is growth capex, deliberate and disclosed, not a cash-conversion problem (CFO/EBITDA held at 0.84). The whole thesis is whether that capex is value-creating, which the panel alone cannot answer. It hands the question to incremental ROIC and the valuation.

Incremental ROIC — the compounder test, and the crux of the whole analysis. Average ROIC (17% in FY24) is depressed by the capital already spent on fabs that are not yet producing. The truer test is what the new capital earned. But here the standard ROIIC = ΔNOPAT ÷ ΔIC runs into exactly the lag the workbook warns about, and reading it naively would be the analyst's biggest possible mistake on this company:

• Window A — FY15→FY19 (pre-build): ΔNOPAT = 5.2 − 3.8 = +$1.4bn; ΔIC = 15.5 − 12.7 = +$2.8bn → ROIIC ≈ 1.4 / 2.8 = 50%. Incremental returns of ~50%, roughly six times the ~8–9% USD hurdle. The reinvestment over this stretch was spectacularly value-creating. This is the compounder signature.
• Window B — FY19→FY24 (the build): ΔNOPAT = 4.9 − 5.2 = −$0.3bn; ΔIC = 28.8 − 15.5 = +$13.3bn → ROIIC ≈ −0.3 / 13.3 ≈ 0%. Read naively, the last five years of reinvestment earned nothing.

The institutional judgment is in reconciling the two. Window B's ~0% is not evidence the moat broke or management destroyed value; it is a timing artifact: ~$13bn of capital was spent on 300mm fabs (FY22–24) whose revenue and profit arrive in FY25–28 as they load, landing on top of a cyclical earnings trough in the denominator year. Computing incremental ROIC to a build-and-trough year is like measuring a farmer's return the season he buys the land and before the first harvest. The correct move is to estimate the forward incremental return the new capacity will earn once loaded and the cycle normalizes: 300mm analog wafers cost roughly 40% less per chip than the 200mm they replace, and loaded analog capacity at TI has historically earned 30–50% ROIC. Even on a conservative assumption, with the new ~$13bn of capital eventually earning, say, 25% at mid-cycle (well below TI's history, generous to the bear), the reinvestment is value-creating three-times-over versus the hurdle. The entire thesis now reduces to a single, judgeable question: will the new 300mm capacity load and earn a mid-cycle ROIC comfortably above ~9%, or will it strand? That is what the reverse DCF prices, the moat work adjudicates, and the scuttlebutt stress-tests. The incremental-ROIC computation did not answer the question — but it isolated it, which is its job.

6.2 Component 2: the industry map

Value chain (Mauboussin supplier→firm→customer) and the profit pool. Upstream: silicon wafers, chemicals, and semiconductor equipment (ASML, Applied Materials, Tokyo Electron: powerful, concentrated suppliers of the tools, but a modest share of TI's cost). The firm: TI designs and manufactures its own analog and embedded chips (an integrated device manufacturer that owns its fabs, unlike fabless peers who rent TSMC). Downstream: TI sells ~100,000 catalog parts to ~100,000 customers across automotive (~35% of revenue), industrial (~40%), and personal electronics/enterprise/comms (the rest), mostly through direct relationships and distribution. The profit pool sits with the chip designer-manufacturers, and TI sits squarely in it: the analog chips are a small fraction of a car's or a factory-robot's bill of materials but are essential, spec'd-in, and command durable pricing, while the equipment suppliers upstream capture a one-time sale and the OEM customers downstream compete in tougher end-markets. TI captures a disproportionate share of the chain's economics, which is exactly why its margins are structurally high.

Porter's five forces (rated for the incumbent):

The five-forces read confirms a structurally attractive industry position: the only meaningfully adverse force is upstream equipment suppliers, and that pressures capex cost, not the recurring margin.

Market-share-stability test (Greenwald). TI's share of the global analog market has held around ~18–19% for a decade, moving well under the ~2%/year instability threshold; the #2–5 (ADI, Infineon, NXP, STMicro) have likewise held roughly stable positions. Stable share among stable incumbents over a full cycle is the single most powerful moat signal Greenwald identifies: no competitor can profitably take share, which is the operational definition of a barrier to entry. The one watch-item: Chinese analog entrants (3Peak, SG Micro and others) gaining at the low end domestically. Real, but so far a small-part, price-competitive slice, not a share-of-the-profit-pool threat. Flag it for the moat-direction call and the bear.

6.3 Component 3: the four-lens moat verdict

Run all four lenses explicitly; the verdict is proven in the numbers, not asserted.

Lens 1 — Dorsey's five sources. Three apply, strongly; two do not. Cost advantage (strong): TI manufactures on owned, largely depreciated 300mm fabs at the lowest per-chip cost in analog, a structural, widening edge (300mm cuts unit cost ~40% vs 200mm), and the reason the current capex, painful as it is, deepens the moat. Switching costs (strong): analog parts are designed in to a customer's product and stay for the product's life (often 5–15 years in autos and industrial); re-qualifying a different supplier's part is costly and risky, so incumbency is sticky. Intangibles / catalog breadth (medium-strong): ~100,000 parts, deep direct-sales and distribution relationships, and a reputation for supply reliability create a one-stop breadth rivals cannot quickly match. Network effects do not apply (this is not a two-sided market). Efficient scale: partially (analog is fragmented, so it is less a "one-firm-fits-the-market" than manufacturing-scale economies, already captured under cost advantage). False-moat check: the moat is emphatically not "great management" or "high share" as such. It is confirmed in the numbers below, not in the reputation.

Lens 2 — Greenwald (barriers to entry + share stability). Collapse the forces to the one that matters: can a new entrant earn its cost of capital? No. It would need to build 300mm fabs (the multi-billion, multi-year program you are literally watching TI struggle to finance), assemble a 100,000-part catalog, and dislodge decade-long design-ins, all to enter a market where the incumbent already produces at lower cost. The share-stability test passes (§6.2): ~19% share, stable a decade, is Greenwald's confirmation that the barrier is real.

Lens 3 — Helmer's 7 Powers (Benefit + Barrier). Three powers are clearly present. Scale economies: 300mm manufacturing spreads fixed cost over enormous volume (Benefit: lower unit cost; Barrier: an entrant at sub-scale cannot match it). Switching costs: design-in lock-in (Benefit: durable pricing and retention; Barrier: the customer's re-qualification cost). Cornered resource / process power: decades of analog design know-how and manufacturing yield learning (Benefit: breadth and reliability; Barrier: tacit, cumulative, not buyable). Each passes the "'me-too' won't do" test.

Lens 4 — Mauboussin (persistent ROIC > WACC + CAP). The numbers prove it and date it: operating ROIC ran 30–48% for the decade through FY22 against a ~9% WACC, a 20-to-40-point spread sustained across a full cycle, gross margin stable at 58–69%, share stable at ~19%. That is a wide moat with a long Competitive Advantage Period. Analog product cycles are long, design-ins durable, and the manufacturing cost edge compounds. The current ROIC compression to 17% is the analyst's key discrimination: is it moat erosion (permanent, with competition or obsolescence taking the returns) or investment lag (temporary, with capital spent ahead of the profit it will earn)? Every piece of evidence says lag, not erosion: the share is stable, the gross margin fell on utilization and new-fab depreciation (cyclical/temporary) not on price competition (permanent), and the capex deepens the very cost advantage that is the moat. Moat verdict: wide, sourced in cost advantage + switching costs + catalog breadth, historically widening; direction currently obscured by the capex cycle but most likely still widening, with one genuine watch-item (Chinese low-end share) to monitor, not yet to price as erosion.

6.4 Component 4: the three-way valuation → a defensible range

Step 1 — WACC, built from scratch (method per M3.03; live inputs pulled mid-2026). Risk-free (US 10-yr) ~4.3%; equity risk premium (Damodaran implied) ~4.5%; bottom-up beta for analog semis ~1.10 (mild cyclicality). Cost of equity = 4.3% + 1.10 × 4.5% = ~9.25%. Cost of debt (A-rated, pre-tax ~5.0%; after-tax at ~13% ≈ 4.35%). Market weights: equity ~$173bn, debt ~$13bn → ~93% / 7%. WACC = 0.93 × 9.25% + 0.07 × 4.35% ≈ 8.9%, call it 9.0%.

Step 2 — the DCF (FCFF; base/bull/bear from stated assumption changes). The forecast is disciplined by the rebuilt history and the moat verdict: revenue recovers from the FY24 trough of $15.6bn as the cycle normalizes and new capacity loads; gross margin recovers toward the low-60s (utilization returns, new depreciation offsets some); capex falls back from ~$5bn toward ~$3bn once the build completes; so FCFF inflects sharply over FY25–29.

• Base case. Revenue ~+8%/yr to ~$23bn by FY29; EBIT margin recovers to ~42%; capex normalizes to ~$3bn; FCFF ramps FY25→FY29 ≈ $2.5, $4.0, $6.0, $7.5, $8.5bn. PV of explicit FCFF at 9% ≈ $21bn. Terminal (Gordon on $8.5bn, g = 3.5% ≤ US nominal GDP, terminal ROIC ~30% ≫ WACC per the moat) = 8.5 × 1.035 / (0.09 − 0.035) = $160bn at FY29; PV (×0.650) ≈ $104bn. EV ≈ $125bn; less net debt $5bn → equity ≈ $120bn; ÷ 912m shares → ~$130/share.
• Bull case. Faster load + the dependable-Western-capacity premium: normalized FCFF ~$10bn, g = 4%, and a WACC of 8.5% (a lower risk premium for the widened moat) → equity ≈ $180bn → ~$200/share.
• Bear case. Weak loading + Chinese low-end share loss: normalized FCFF ~$5bn, g = 2.5%, WACC 9.5% → equity ≈ $75bn → ~$82/share.

Step 3 — relative valuation (comps, normalized). The analog and broad peers, Analog Devices (ADI), Microchip (MCHP) and NXP, trade ~20–25× forward earnings and ~15–20× EV/EBITDA. TI at ~$190 is ~36× trough FY24 earnings ($5.28 EPS), optically expensive, but earnings are trough. On normalized mid-cycle EPS (~$8–9, if NI recovers to ~$8bn), TI is ~21–22×, a premium to peers that its higher margins, ROIC, and FCF discipline arguably justify, but not cheap. Comps verdict: fairly valued on normalized earnings, expensive on trailing. The multiple is already paying for the recovery.

Step 4 — reverse DCF (what is priced in). At ~$190, EV ≈ $178bn. Hold WACC at 9% and solve the Gordon relation for the perpetual growth the price implies if you credit a normalized FCFF: with normalized FCFF ≈ $8.5bn, implied g = WACC − FCFF/EV = 9.0% − 8.5/178 = 9.0% − 4.8% = ~4.2%. So the price embeds two assumptions stacked: (a) that FCFF recovers all the way from today's $1.5bn to ~$8.5bn, the old "$8–9/share FCF" aspiration, achieved and roughly on time, and (b) ~4.2% perpetual growth thereafter, modestly above US nominal GDP. That is a full embedded story: not euphoric, but assuming the recovery lands and the moat compounds slightly above the economy forever. It leaves no margin of safety for the recovery arriving late, smaller, or through a deeper cycle.

Triangulation → the range and the verdict. DCF base ~$130, bull ~$200, bear ~$82; comps ~$150–180 on normalized earnings; reverse DCF says the ~$190 price already credits a full, on-time recovery plus above-GDP growth. The three methods point the same way: a defensible range of roughly $120–$200, with a base around $130–150, and a current price ($190) sitting in the upper half. The honest verdict is not "cheap" and not "broken". It is a wonderful business at a full price, with limited-to-no margin of safety at $190. The margin of safety appears below ~$150, where the base case and a genuine discount align. This is the kind of conclusion that separates institutional discipline from quality-story enthusiasm: recognizing a great business and still concluding "watch, not buy, at this price", and naming the price at which that changes.

6.5 Component 5: management, capital allocation & incentives (from the DEF 14A)

The ten-year capital-allocation record (read off the history, judged on incremental returns). TI's doctrine, stated in its investor materials for over a decade, is a single sentence: maximize long-term free cash flow per share. The record matches the words. Through FY22, essentially 100% of free cash flow was returned: a steadily growing dividend (raised ~21 consecutive years) plus opportunistic buybacks that reduced the share count from over 1,600m (mid-2000s) to ~912m today, roughly a 45% reduction, executed disproportionately when the stock was cheaper. Reinvestment was modest and earned the ~50% incremental ROIC of Window A. This is a textbook capital-allocation record: reinvest what earns high returns, return the rest, buy back stock with discipline, raise the dividend as cash grows.

The current, deliberate shift, and why it is the whole test. Since FY22, TI has paused most buybacks, taken on ~$13bn of gross debt, and redirected cash into the 300mm fab build: a disclosed, deliberate choice to reinvest at scale for the first time in the company's modern history. This is the single biggest test of the management's capital-allocation reputation: a great-allocator track record is now being spent on one enormous bet. The bull read: disciplined allocators who returned cash for two decades do not suddenly build empires. They see a high-return reinvestment (300mm cost advantage + geopolitically-dependable capacity that Western auto/industrial customers will pay to secure) and are taking it. The bear read: even great allocators over-build at cycle peaks, and the aspiration has already slipped (the "$8–9/share FCF by 2026" framing was quietly softened). The incentive read is how you adjudicate between them.

The DEF 14A dissection. Read the proxy for the metrics that actually drive pay: historically, TI's incentive compensation has been weighted toward free-cash-flow-per-share growth and relative total shareholder return, with meaningful executive stock-ownership requirements. That is an incentive structure that rewards exactly the FCF/share discipline the doctrine preaches and that the current capex temporarily depresses. That alignment is the reassuring part: the executives are paid on the metric the fab build is currently hurting, which argues they believe the build will raise long-term FCF/share, not just grow the company. The item to scrutinize (and to flag if it has changed): whether the comp committee has adjusted the metrics or added "strategic investment" carve-outs that would let management collect on empire-building even if FCF/share never recovers. That adjustment, if present, would convert the incentive from a discipline into a license. An institutional read checks the proxy's metric definitions year-over-year for exactly this. (In the illustrative base case, the metrics remain FCF/share-and-TSR-weighted, so the prediction is continued discipline, but the analyst states the check explicitly rather than assuming it.)

Prediction vs record. The incentive structure predicts disciplined, returns-focused allocation; the ten-year record confirms it; the current capex is consistent with it if the reinvestment earns its cost of capital (which the moat work says it should). Verdict: A-grade capital allocators, strongly aligned, making the biggest bet of their tenure, and the incentive read gives real (not blind) confidence that the bet is a returns judgment, not an empire. The residual risk is precisely that a great reputation gets over-trusted through one capex cycle; that risk goes into the pre-mortem.

6.6 Component 6: the scuttlebutt findings

Fisher's method, aimed at the variant question (does the new capacity load and the moat hold?), via free channels. Mark which of the fifteen points the numbers already answered (margin, dilution, the profit outlook: skip those) and spend field time on demand signal, culture, and the industry tell.

• Customer / demand signal (the crux). Check distributor availability and lead times at Digi-Key and Mouser (public): analog part lead times normalizing from the shortage-era highs signals the destocking is maturing (a cycle-turn tell). Design-engineer forums (EEVblog, Reddit r/AskElectronics, TI's own E2E community) show TI parts remaining the default design-in choice for power management and signal chain: the switching-cost moat, visible in behavior. Finding: the design-in stickiness is real; the demand-timing is the open question, and lead-time normalization is the metric to watch.
• Competitor commentary (expert-network substitute). ADI's, Microchip's, and NXP's latest calls all describe the same auto/industrial destocking and a tentative bottoming, triangulating that the FY23–24 weakness is cyclical and industry-wide, not TI-specific share loss. Finding: consistent with lag-not-erosion.
• The Chinese-competition watch-item. Trade-press and Chinese-peer (3Peak, SG Micro) disclosures show real low-end share gains inside China, on price, but concentrated in commodity parts, not the design-in-heavy auto/industrial catalog. Finding: a genuine long-run watch-item for the low end, not yet a profit-pool threat; goes to moat-direction and the bear.
• Culture / execution (Glassdoor trend + text). An engineering-driven, cost-disciplined culture with stable senior tenure; the trend is steady, not deteriorating. Finding: consistent with the disciplined-allocator claim; no red flag.
• Build-progress alt-data. Job postings and local reporting around the Sherman, Texas and Lehi, Utah fab sites confirm the build is proceeding on the disclosed timeline. Finding: execution on the capex is real, which is necessary (not sufficient) for the recovery.

Scuttlebutt verdict: the mosaic supports lag, not erosion: the moat's switching costs are visible in engineer behavior, the weakness is industry-wide and cyclical, and the one real threat (Chinese low-end) is contained for now. Each source's bias is noted (forums skew enthusiast; competitor calls talk their own book; Glassdoor skews recent-leaver), so no single source is load-bearing. The triangulation is.

6.7 Component 7: the earnings-call audit + steelman-the-bear

Call audit (eight calls, FY22 peak → FY24 trough; the four tells + promise ledger). TI's calls are, by reputation and in the transcripts, unusually candid and consistent: management answers the question actually asked (rather than pivoting to a prepared line), frames the downturn straightforwardly as cyclical destocking, and has preached the identical FCF/share doctrine for 15+ years, a long, largely-kept promise ledger (the historical FCF/share compounding delivered on the words). The one place to press candor: the "$8–9/share free cash flow by 2026" framing from the 2022 capital-management materials, which management later softened as demand weakened and capex rose. Did they own the slip or move the goalposts? The evenhanded read: the softening was partly demand-driven (a genuine cyclical miss, honestly explained) and partly a choice to invest more (a strategy change, disclosed). They explained both rather than hiding the gap, which reads as candor under pressure rather than goalpost-moving. Candor verdict: strong, with the FCF/share-aspiration slip as the honest asterisk to keep watching.

Steelman the bear (the highest-value hour: argued stronger than the shorts, then answered).

Answering the steelman. The valuation-bear is correct and conceded, which is precisely why the verdict is "watch, not buy, at $190" and the margin of safety is named at ~$150. The two thesis-bears are the real contest. Against "empire-building": the incentive read (pay on FCF/share) and the 20-year discipline argue this is a returns judgment, and the 300mm cost advantage widens the moat, so under-utilization is a timing cost, not a permanent impairment — but the bear is right that the timing risk is real and unpriced. Against "China erosion": the threat is concentrated in the commodity low end, while TI's profit pool is design-in-heavy auto/industrial where switching costs bind, and "geopolitically-dependable Western capacity" is a feature TI's Western customers will pay for. But the bear is right that China is a large end-market and a genuine long-run watch-item. The single strongest thesis-level bear point is the first, the capex-timing risk, because it attacks the business's cash economics on a schedule the market has assumed away. The thesis survives the steelman, but narrower and more honest: the business and the reinvestment are sound; the disagreement with the market is about timing and price, not quality.

6.8 Component 8: the one-page thesis

Texas Instruments (TXN) — one-page thesis · price ~$190 · data through FY24 · sources: 10-Ks FY15–24, FY24 DEF 14A, 8 transcripts, ADI comps · illustrative 1. The business. The world's #1 analog and embedded semiconductor maker (~19% of a fragmented ~$80bn analog market), designing and manufacturing its own ~100,000 catalog parts for auto (~35%) and industrial (~40%) customers on owned 300mm fabs. The real profit engine is Analog: small-BOM, design-critical chips with long product lives and durable pricing, sold to 100,000 customers with no concentration. 2. Why it is a good business. A wide moat from cost advantage (lowest per-chip cost on owned, depreciating 300mm fabs, the very edge the current capex deepens), switching costs (design-in lock-in for the product's 5–15-year life), and catalog breadth, proven in the numbers: operating ROIC 30–48% for a decade against a ~9% WACC, gross margin stable 58–69%, share stable ~19% (Greenwald's test passed). Capital allocators are A-grade and aligned: 100% of FCF returned for two decades, share count down ~45%, dividend up 21 straight years, and pay tied to FCF/share (checked in the proxy). 3. The variant perception (the heart). The market prices a full, on-time recovery of free cash flow from today's ~$1.5bn to the old ~$8–9/share aspiration, plus above-GDP growth (reverse DCF: ~4.2% implied perpetual g on normalized FCF). My variant view is two-sided and, net, more cautious than the price: near-term, consensus underappreciates how long the capex-and-depreciation drag suppresses FCF/share, a multi-year "prove-it" period in which the stock can de-rate on a demand recovery that arrives late or shallow; longer-term, the market may underprice the widened 300mm and dependable-capacity moat. The asymmetry is therefore poor at $190 (no margin of safety for the timing risk) and attractive below ~$150 (where you are paid to wait through the prove-it period for a moat that is compounding). 4. The three things that must go right (falsifiable). ① The 300mm fabs load and gross margin recovers toward the low-60s by ~FY27; ② the auto/industrial demand cycle troughs and turns (lead-time normalization → order recovery); ③ China low-end competition stays contained to commodity parts, not the design-in profit pool. 5. Valuation & expected return. Three-way range ~$120–$200 (DCF base ~$130, bull ~$200, bear ~$82; comps ~$150–180 normalized; reverse DCF says $190 embeds a full recovery + above-GDP growth). Interested below ~$150 (margin of safety appears); watcher at ~$190 (fully priced). At $190, expected return is roughly the FCF-recovery growth minus the de-rating risk: positive-but-thin, not a margin-of-safety buy. 6. Sell criteria (written now, before ownership). Exit / stay-out if: (a) fab utilization or gross margin fails to recover by FY27 (the thesis-bear confirmed); (b) China share loss reaches the design-in catalog, not just the low end (moat erosion, not lag); (c) capital allocation deteriorates, with the FCF/share doctrine abandoned or the proxy metrics quietly changed to reward size; (d) price runs far above the ~$200 bull case with no fundamental change.

All five spine questions are answerable from this page; the variant perception is one falsifiable, two-sided sentence; and the valuation is an honest range whose width reflects a genuinely hard-to-time recovery.

6.9 Component 9: the pre-mortem → monitoring dashboard

"It is 2029. This was a mistake — I bought at $190 and lost money. What happened?" Specific, company-level failure paths, ranked by probability × severity, each wired to a measurable trigger. Those triggers are the monitoring dashboard and map onto the sell criteria above.

The pre-mortem's payoff: every failure path has a countable early-warning sign (utilization and gross margin, China revenue, proxy metrics, net leverage), and those signs are exactly the sell criteria in §6.8. This is what converts a hopeful "great business, will recover" into a falsifiable, monitorable thesis: you have written, in advance, the specific numbers that would prove you wrong, and you will re-run them on every 10-K, every call, and any >20% price move.

6.10 Self-grade against the institutional rubric (§8)

The whole package, scored against the institutional rubric as a hostile grader would (anchors in §8). Shown here so you can see what an institutional-grade total looks like and where even a strong package leaves points on the table.

Total: 35/36. Comfortably institutional-grade (the bar is ≥30/36 with no hard gate below 1, see §8). Note where it left a point. Communication craft (criterion 18) cost it one: the analysis is complete and conclusion-first, but the exhibits are not yet presentation-polished. That is deliberate and correct: the capstone certifies the analysis; M10.03 polishes the communication. Note also what makes it institutional rather than merely competent: the incremental-ROIC reconciliation (not just the computation), the three-way triangulation to a range with a named margin-of-safety price, the answered steelman that left the thesis narrower and more honest, and a two-sided variant perception that is cautious on a beloved compounder, evenhanded by construction, and ending in a decision ("watch below $150") rather than a description.

6.11 Extending component 4 (A): the DCF as a sensitivity surface

Two short exhibits extend the §6.4 valuation, the kind a strong package attaches to component 4. Both reconcile to the base case above, and both make the valuation range honest rather than decorative. All figures are illustrative; recompute against the filings.

A single "fair value" hides the one thing a PM most needs to see: how the answer moves when the assumptions move. So express the §6.4 DCF as a surface. First, reconstruct the base case exactly, to anchor the grid to figures you have already defended:

• Explicit FCFF FY25–29 = [2.5, 4.0, 6.0, 7.5, 8.5], discounted at the 9% WACC → PV ≈ $21.1bn.
• Terminal value on the FY29 FCFF of $8.5bn at g = 3.5%: 8.5 × 1.035 / (0.09 − 0.035) = $160.0bn; discounted five years (1/1.09^5 ≈ 0.650) → PV ≈ $104.0bn.
• EV ≈ 21.1 + 104.0 = $125.1bn; less net debt $5bn → equity ≈ $120.1bn; ÷ 912m shares → ≈ $131.7/share, i.e. §6.4's "~$130" base, rebuilt to the dollar. (This is the cross-check that ties the exhibit to the module's own figure.)

Now hold WACC at 9% and the explicit-period PV at $21.1bn, and flex the two terminal levers: the normalized (terminal) FCFF the perpetuity capitalizes, and the terminal growth g:

Reading the surface. The base cell is the $132 you just rebuilt. Holding WACC fixed, the value ranges ~$96–$166 across plausible terminal assumptions, a roughly ±25% swing driven entirely by two numbers, because on this business the terminal value is ~80% of EV. That is the institutional point of a sensitivity table: the per-share value is a function, and its dispersion is information about how hard the company is to value (Common mistake 4), not a precision to be hidden behind a single figure. Note too that this grid is narrower than §6.4's full $82–$200, because the full bull and bear cases also flex the WACC and the near-term recovery path, which the next exhibit decomposes.

6.12 Extending component 4 (B): the bull/bear bridge

§6.4's three legs are not moods; each falls out of a stated assumption change. A bull/bear bridge makes that explicit: a waterfall that attributes the move from the bear value to the bull value to each lever in turn. It is the direct antidote to the false-range failure (Common mistake 4): a range you cannot attribute to specific assumptions is decoration.

Define the three cases on the same engine as §6.11, with clean multipliers on the whole FCFF path (ramp and terminal), so the legs are internally consistent:

These land squarely on §6.4's illustrative DCF legs (bear ~$82, base ~$130, bull ~$200), reproduced here from clean, stated inputs rather than asserted. Now bridge bear → bull, changing one lever at a time:

Reading the bridge. All three levers are material, at ~$30–44 each, so no single assumption is the valuation; recovery strength is the largest contributor, but the growth and discount-rate judgments together move the value as much again. The +$113 total swing is honest information: three independent judgments each worth $30+/share is exactly what a genuinely hard-to-value, mid-transition business looks like, and a suspiciously narrow range would be the tell that the assumptions were never truly varied. Two cautions travel with the exhibit: the attribution is path-dependent (a different order reshuffles each lever's share through interaction terms, so read the ranking and magnitudes, not the last dollar), and the bridge prices only the levers it names. Finally, tie it back to expectations: the reverse DCF's ~4.2% implied growth at the $190 price sits between the base's 3.5% and the bull's 4.0%. The market is paying up toward the bull leg, which is precisely §6.4's "price in the upper half, no margin of safety" verdict, now shown rather than asserted.

Practice set

Ten problems that drill the skills of running a capstone: target selection, the incremental-ROIC-lag judgment, reverse-DCF inversion, three-way triangulation, rubric-grading, the incentive read, the moat-erosion-vs-lag discrimination, and the hostile-PM self-review. Ramped guided (P1–P4) → independent (P5–P8) → timed exam-conditions (P9–P10). Companies are synthetic unless named (clean numbers, labeled synthetic). Produce your full answer before reading the solution.

P1 (guided — target selection). You have already studied, earlier in the program, Costco, Sherwin-Williams, Copart, Apple, Visa, and Bajaj Finance. From the §4.2 list you are drawn to Mastercard, Nucor, and U.S. Bancorp. You want the target that most tests a valuation judgment (rather than an accounting or governance judgment), because that is your weaker edge. Which do you pick, and why? And which one would you pick instead if you wanted to test the sector lens you are weakest in?

Solution. For the valuation test, pick Mastercard: its accounting is simple and its governance clean, so the entire difficulty concentrates exactly where you want it: is a wonderful business already fully priced? The reverse DCF is the whole thesis, which is the valuation muscle you named as weak. Nucor tests cyclical normalization (also valuation, but entangled with cost-curve mechanics) and U.S. Bancorp tests the bank lens (a different toolkit: P/B–ROE, NIM, CET1). So if instead you wanted to stretch the sector lens you are weakest in, pick U.S. Bancorp, because a bank exercises the one valuation-and-analysis toolkit no non-financial on the list touches. The meta-lesson: choose the target for the specific edge you want to stretch, the same deliberate-practice logic as M8.05's target bank, now at capstone scale.

P2 (guided — incremental ROIC and the lag). Synthetic "Foundry Co." NOPAT and invested capital: FY19 NOPAT $2.0bn, IC $8.0bn; FY22 NOPAT $3.2bn, IC $11.0bn; FY25 NOPAT $3.0bn, IC $20.0bn (FY23–25 was a heavy capacity build). Compute incremental ROIC for FY19→FY22 and FY22→FY25. Interpret. What one further piece of evidence decides whether the FY22→FY25 number is a red flag or an artifact?

Solution. FY19→FY22: ΔNOPAT = 3.2 − 2.0 = +$1.2bn; ΔIC = 11.0 − 8.0 = +$3.0bn → ROIIC = 1.2/3.0 = 40%. Elite: reinvestment earning far above any reasonable hurdle. FY22→FY25: ΔNOPAT = 3.0 − 3.2 = −$0.2bn; ΔIC = 20.0 − 11.0 = +$9.0bn → ROIIC = −0.2/9.0 ≈ −2% ≈ 0%. Read naively, the recent $9bn of capital earned nothing. Interpretation: this is the exact TXN pattern, where the build-window number is dominated by capital that is in the denominator before the profit it will produce is in the numerator (plus, if FY25 is a cyclical trough, a depressed numerator). The deciding evidence: whether the newly-built capacity is loading: utilization trending up, and a credible estimate of the mid-cycle ROIC the capacity earns once full. If utilization is ramping and loaded capacity historically earns ~30%, the ~0% is a timing artifact and the reinvestment is value-creating; if the capacity is finished and still idle with no demand in sight, the ~0% is the beginning of a real erosion. Incremental ROIC over a build window isolates the question; it does not answer it.

P3 (guided — reverse DCF). Synthetic "Rails Inc." trades at a market cap of $90bn with net debt $30bn (EV $120bn) and normalized FCFF of $6.0bn. Your WACC estimate is 8.0%. Using the Gordon inversion, what perpetual growth does the price imply? Is that demanding, given US nominal GDP of ~4%?

Solution. Gordon inversion: implied g = WACC − FCFF/EV = 8.0% − (6.0/120) = 8.0% − 5.0% = 3.0%. The price implies ~3% perpetual FCFF growth, below nominal GDP of ~4%. That is not demanding; the market is pricing sub-GDP growth forever, which for a real business with any pricing power is conservative-to-cheap. This is the opposite of the TXN case (where the implied ~4.2% was above GDP and demanding): the same arithmetic, opposite verdict, because the implied growth sits below rather than above the economy's rate. The lesson: the reverse DCF's output is meaningless until you benchmark the implied growth against nominal GDP and the base rate. A number is not a verdict.

P4 (guided — spot the missing deliverable). A learner's capstone package on a synthetic SaaS company contains: a hand-built ten-year history with incremental ROIC; an industry map; a four-lens moat verdict; a full DCF with base/bull/bear; a comps table; a DEF 14A incentive read; scuttlebutt across four channels; an earnings-call audit; a one-page thesis; and a pre-mortem. The rubric-grader flags it as not institutional-grade despite all that. Which required component is missing, and why is its absence fatal?

Solution. The reverse DCF is missing. The package has a DCF and comps but never inverted the price to read what the market is implying. Its absence is fatal because it is a hard-gate criterion (§8) and because without it there is no anchor for the variant perception: you cannot say what the market has wrong if you never computed what the market believes. A DCF tells you what you think the business is worth; only the reverse DCF tells you what the price assumes, and the gap between those two is the entire thesis. A package with intrinsic and relative valuation but no expectations read describes a company's worth without ever engaging the market's view, which is the definition of a book report with a valuation appendix (Common mistake 1).

P5 (independent — triangulate a range). Synthetic "Brandco." Your three methods produce: DCF base $80/share, bull $115, bear $55; comps imply $70–90 on normalized earnings; reverse DCF says the current $95 price embeds ~7% perpetual growth (vs ~4% nominal GDP) on already-normalized cash flow. State the defensible range, the verdict at $95, and the price below which a margin of safety appears. Then state whether the natural variant perception is bullish or bearish and why.

Solution. Defensible range ~$55–$115, base cluster ~$70–90 (DCF base $80 and comps $70–90 agree; the bull $115 and bear $55 mark the tails). Verdict at $95: the price sits above the base cluster and the reverse DCF says it embeds ~7% perpetual growth, nearly double nominal GDP, so the price is demanding, with no margin of safety. Margin of safety appears below ~$75 (the lower base cluster, where DCF base and comps overlap with a discount). The natural variant perception is bearish/cautious: the market is extrapolating ~7% forever, which the base rate says few firms achieve for long, so unless you can name the specific durable moat that puts this firm in the right tail, the honest variant view is "the implied growth is too optimistic — pass or short-watch." (If you could name that moat convincingly, the view flips: the market's 7% is right and you would need a different edge to disagree, in which case there is no variant view and the answer is "no edge, pass.")

P6 (independent — grade a thesis excerpt). Grade this one-page-thesis variant-perception paragraph against the rubric's hard gates: "MegaRetail is a fantastic business with a strong brand and great management. It has grown earnings 15% a year for a decade and should keep doing so. The stock looks reasonably valued at 25× earnings given the growth. I think it's a buy." Which hard-gate criteria fail, and what is the single most important fix?

Solution. Multiple hard gates fail. Variant perception (fatal): there is none; "should keep doing so" and "reasonably valued" restate the consensus; nothing says what the market has wrong and why you might be right. Moat proven in numbers: "strong brand and great management" are two of the four false moats (brand asserted, not proven; "great management" is not a moat), with no ROIC-persistence proof. Reverse DCF / what's priced in: "25× given the growth" is not an inversion; it never solves for the growth/duration the price implies. False precision / verdict: ends in "buy" with no range, no margin of safety, no sell criteria. The single most important fix: run the reverse DCF to establish what 25× is actually assuming (e.g., "25× implies ~11% growth for a decade then fade"), then state whether the rebuilt evidence supports a different belief than that, which is the only thing that turns this from advocacy into a thesis. Without a variant perception anchored in the reverse DCF, no amount of polishing the prose helps.

P7 (independent — the incentive read). Two synthetic companies. Company A: executive bonus is 70% EPS-growth, 30% revenue-growth; no ROIC or FCF metric; modest stock-ownership requirement. Company B: bonus is 50% ROIC, 30% FCF/share growth, 20% relative TSR; large stock-ownership requirement; a growth gate that caps payout if revenue falls. Predict each management's capital-allocation bias, and name one specific behavior you would look for in each ten-year record to confirm.

Solution. Company A is incentivized toward buyback-at-any-price and dilutive M&A: EPS growth can be manufactured by repurchasing stock regardless of price and by acquiring earnings (even value-destructively, as long as the deal is EPS-accretive), and revenue-growth pay rewards size. Confirm by looking for: buybacks that continued (or accelerated) when the stock was expensive, and acquisitions whose price/goodwill suggests EPS-accretion math rather than returns discipline. Company B is incentivized toward disciplined, returns-focused allocation: ROIC and FCF/share pay punishes value-destructive growth, the ownership requirement aligns them with per-share value, and the growth gate stops them from shrinking to hit ROIC. Confirm by looking for: buybacks concentrated when the stock was cheaper, reinvestment/M&A that raised (not diluted) incremental ROIC, and a rising dividend funded by real FCF. The lesson: the proxy predicts behavior; the ten-year record confirms or refutes the prediction, and the agreement (or gap) between them is itself a finding.

P8 (independent — erosion vs lag). Two synthetic companies show ROIC falling from 35% to 18% over three years. Company X: gross margin fell from 60% to 52% while a new competitor's share rose from 5% to 18% and X's share fell from 40% to 30%; capex was flat. Company Y: gross margin fell from 60% to 54% on lower factory utilization during an industry-wide destocking, share held at ~40%, and capex tripled as Y built new capacity. For each, is the ROIC decline moat erosion or investment lag? What decides it?

Solution. Company X = moat erosion. The tells are all "permanent-competition" signals: gross margin fell and share was lost to a named entrant that gained, with flat capex (so it is not an investment-timing story). Falling returns caused by a competitor taking price and share is the moat weakening: the ROIC decline is real and likely to continue. Company Y = investment lag. The tells are all "timing/cyclical" signals: gross margin fell on utilization (temporary) during an industry-wide destock (not company-specific), share held (no competitor is winning), and capex tripled (capital is in the denominator ahead of the profit it will earn). Y's ROIC decline is most likely an artifact of the cycle plus the build, exactly the TXN pattern. What decides it: the trio of share direction, the reason for the margin fall (price/competition vs utilization/cycle), and whether capital was being built ahead of profit. Erosion shows falling margin + lost share + a winning rival; lag shows falling margin on utilization + held share + a capex surge. Misreading lag as erosion (or vice versa) is the single most expensive analytical error on a capital-heavy compounder.

P9 (timed — the hostile-PM read-through, ~20 min). You are handed a capstone package on synthetic "CloudCo." The body is excellent: a rebuilt history showing 25% ROIC, a four-lens moat verdict, a full three-way valuation concluding the stock is worth $140–180 vs a $150 price, a clean incentive read, and a monitored pre-mortem. The one-page thesis's variant-perception line reads: "CloudCo is a high-quality compounder trading roughly in line with intrinsic value; I expect it to compound at its ROIC." Run self-review Pass 2 (hostile PM). Does this package clear the bar? What is the precise problem, and the fix?

Solution. It does not clear the bar, despite an excellent body, and this is the most important self-review lesson. Pass 2 asks: is there a genuine variant perception? Here there is none: "trading roughly in line with intrinsic value" and "compound at its ROIC" is an explicit statement that the analyst agrees with the market. If your valuation ($140–180) brackets the price ($150), you have found the stock to be fairly valued, which is a legitimate finding, but it means there is no edge and no variant view, so the honest output is "fairly valued — no variant perception — watchlist, act only on a price dislocation," not a thesis dressed as one. The precise problem: the package mistakes a thorough description that concludes "fairly valued" for a thesis, when a thesis requires a disagreement with the market. The fix (one of two honest paths): either (a) find a genuine disagreement: return to the reverse DCF, and if the price implies something the rebuilt evidence contradicts (e.g., the market prices 15% growth but the moat/runway supports 20%), that is the variant view; or (b) conclude honestly that there is no edge here and file it to the watchlist with a target entry price. Manufacturing a fake disagreement to have "a thesis" is the worse sin. A capstone that ends in "fairly valued, no edge, here's my entry price" is institutional-grade; one that pretends to a variant view it does not hold is not.

P10 (timed — sequence a bank capstone, ~15 min). You have chosen U.S. Bancorp. Sketch how the §4.4 ten-day plan bends for a bank: name the three biggest changes to the day-by-day sequence and the deliverable spec, versus the default (non-financial) plan.

Solution. Three changes. (1) The history and "the machine" (days 2–3) re-centres on the bank spread and asset quality, not a P&L-to-FCF walk: build NIM, the loan/deposit mix and CASA-equivalent (non-interest-bearing deposits), the efficiency ratio, credit costs / net charge-offs, and CET1 across the decade. Note that a bank has no clean free cash flow, so the FCF rows and the FCFF-DCF are replaced. (2) The valuation (days 6–7) switches toolkits: the DCF becomes an excess-return / dividend-discount or a residual-income model, and the reverse DCF becomes a justified-P/B inversion: P/B = (ROE − g)/(r − g), solved for the ROE the price implies, compared to the sustainable through-cycle ROTCE. Comps become P/B-vs-ROE and P/E, benchmarked to peer banks. (3) The risk/pre-mortem (days 5, 10) re-weights to balance-sheet and regulatory tail risks: asset-quality deterioration (the SMA/net-charge-off trajectory), deposit flight / funding (post-2023 a live risk), interest-rate sensitivity of the securities book, and capital adequacy under stress, because a bank's disaster paths are balance-sheet events, not demand shortfalls. The moat work (deposit franchise / low-cost funding), incentives read (proxy), scuttlebutt, and one-page-thesis structure are unchanged in shape; the lens is the bank lens (M5.01) throughout. The meta-lesson: the nine deliverables and the numbers-before-narrative order are invariant; the sector dictates the KPIs, the valuation method, and where the risk lives.

P11 (guided — the sensitivity surface). SignalCo (synthetic), a US analog compounder mid-recovery. The explicit-period PV of forecast FCFF is $18.0bn at a 9.0% WACC; you are testing the terminal value. Normalized (terminal) FCFF $6.0bn, net debt $4.0bn, 500m shares. Compute the per-share equity value if terminal growth g is (a) 3.0% and (b) 4.0%, and say what the gap teaches.

Solution. Terminal value = FCFF × (1+g) ÷ (WACC − g), then discounted five years at 1/1.09^5 ≈ 0.650. (a) g = 3.0%: TV = 6.0 × 1.03 ÷ (0.09 − 0.03) = 6.18 ÷ 0.06 = $103.0bn; PV = 103.0 × 0.650 = $66.9bn; EV = 18.0 + 66.9 = $84.9bn; equity = 84.9 − 4.0 = $80.9bn; per share = 80.9 ÷ 0.5 = $161.9. (b) g = 4.0%: TV = 6.24 ÷ 0.05 = $124.8bn; PV = $81.1bn; EV = $99.1bn; equity = $95.1bn; per share = $190.2. One percentage point of terminal growth moved the value $28 (≈18%). That is the whole point of a sensitivity table: on a terminal-value-heavy business the answer is a function of assumptions, so a single-point "fair value" hides the very uncertainty that matters most.

P12 (guided — the bull/bear bridge). GridCo (synthetic), a US utility-adjacent compounder. Your base-case value is $100/share. Moving base → bull, three stated assumption changes contribute: a stronger normalized FCFF +$22, a higher terminal g +$12, and a lower WACC +$16. The bear case lowers each by the identical magnitude. (a) Bull and bear values? (b) The defensible range and midpoint? (c) Which lever dominates, and what does the width tell a PM?

Solution. (a) Bull = 100 + 22 + 12 + 16 = $150; bear = 100 − 22 − 12 − 16 = $50. (b) Range $50–$150, midpoint $100. (c) Normalized FCFF (+$22) is the single largest lever, but the three are comparable: no one assumption is the valuation. A $100-wide range on a $100 midpoint is not a failure of precision; it is honest information that the business is genuinely hard to value. The tell of a decorative range (Common mistake 4) is the opposite: a $95–$105 band produced by nudging one model ±5%, which fakes a precision the inputs cannot support. (Bridges are path-dependent through interaction terms; the ranking of levers, not the last dollar, is the robust output.)

P13 (independent — trailing vs normalized multiple). TroughSteel Inc. (synthetic), a US mini-mill at the bottom of its cycle, trades at $120/share. Trailing (trough-year) EPS is $3.00; your normalized mid-cycle EPS estimate is $8.00. Comparable steelmakers trade at ~11× normalized earnings. (a) Trailing P/E? (b) Normalized P/E? (c) Peer-implied value on your normalized EPS? (d) Name the cyclical trap.

Solution. (a) Trailing = 120 ÷ 3 = 40×, optically alarming. (b) Normalized = 120 ÷ 8 = 15×. (c) Peer-implied = 11 × 8 = $88, below the $120 price → expensive versus peers on normalized earnings. (d) The trap is reading the trailing 40× as "expensive" when it is merely trough earnings in the denominator. Its mirror image is the deep-cyclical trailing-P/E trap: the lowest P/E prints at the peak (peak earnings, just before the collapse), so a cheap-looking trailing multiple on a cyclical is often a sell signal, not a buy. Always normalize the denominator to mid-cycle before comparing.

P14 (independent — WACC build + a lagged Gordon value). AnalogCo (synthetic), a US chipmaker. Inputs (illustrative): risk-free 4.3%, equity risk premium 4.5%, beta 1.20; pre-tax cost of debt 5.0%, tax 21%; capital weights 92% equity / 8% debt. (a) Cost of equity (CAPM)? (b) After-tax cost of debt? (c) WACC? (d) Value normalized FCFF $4.0bn as a growing perpetuity at g = 3.5%, discounted back 4 years for the recovery lag; net debt $6.0bn, 300m shares → per-share value.

Solution. (a) ke = 4.3% + 1.20 × 4.5% = 9.7%. (b) kd(after-tax) = 5.0% × (1 − 0.21) = 3.95%. (c) WACC = 0.92 × 9.7% + 0.08 × 3.95% = 9.24%. (d) TV at the normalization date = 4.0 × 1.035 ÷ (0.0924 − 0.035) = 4.14 ÷ 0.0574 = $72.1bn; discount 4 years = 72.1 ÷ 1.0924^4 = 72.1 ÷ 1.424 = $50.6bn; equity = 50.6 − 6.0 = $44.6bn; per share = 44.6 ÷ 0.3 = $148.8. Traps: using the pre-tax 5.0% (overstates WACC), using ke as the discount rate (ignores the cheaper debt), or forgetting to discount the terminal value back. Valuing a mid-trough business as if the normalized cash were already in hand overstates it badly.

P15 (independent — reverse DCF and its benchmark). Toll Co. (synthetic), a US payments network. EV $300bn, normalized FCFF $12bn, WACC 8.0%. (a) Implied perpetual growth via g = WACC − FCFF/EV? (b) US nominal GDP is ~4%; is the implied growth demanding? (c) What single thing would justify paying it?

Solution. (a) g = 8.0% − 12 ÷ 300 = 8.0% − 4.0% = 4.0%. (b) The implied growth equals nominal GDP, so it is not demanding: the price assumes the business compounds free cash flow at roughly the economy's rate forever, which a genuine wide-moat network can plausibly do. (c) A durable moat with a long Competitive Advantage Period and a real reinvestment runway: network effects/switching costs that keep ROIC > WACC and let FCFF grow at ≥ GDP for decades. The reverse DCF alone yields no variant view here (the implied growth is achievable), so the honest output is "fairly-to-reasonably priced — the edge, if any, must come from believing normalized FCFF is higher than $12bn, not from disputing 4%." A number is not a verdict until you benchmark it.

P16 (timed/stretch — triangulate and decide, ~20 min). FabCo (synthetic), a US integrated device-maker mid-build (a TXN-shaped setup). Your work yields: DCF base $95, bull $150, bear $60; comps imply $85–$105 on normalized EPS; the stock trades at $115, where EV is $110bn against normalized FCFF of $5.5bn (WACC 9.0%). In ~20 minutes: (a) run the reverse DCF and state the implied g; (b) benchmark it vs ~4% nominal GDP; (c) state the defensible range, the verdict at $115, and the margin-of-safety price; (d) is the natural variant perception bullish or bearish, and name one pre-mortem break-variable.

Solution. (a) g = 9.0% − 5.5 ÷ 110 = 9.0% − 5.0% = 4.0%. (b) Equal to nominal GDP, and not extreme in isolation, but the price stacks two assumptions: that FCFF fully recovers to the normalized $5.5bn and then grows at 4% forever. (c) Defensible range $60–$150, with a base cluster $85–$105 (DCF base $95 and comps agree). At $115 the price sits above the base cluster and embeds the full recovery plus GDP-rate growth → fully valued, no margin of safety; the margin of safety appears below ~$90 (base cluster with a discount). (d) The natural variant perception is cautious/bearish on timing: the price assumes the recovery lands on schedule, so the disagreement is about when/whether the fabs load, not business quality. Break-variable for the pre-mortem: fab utilization / gross-margin recovery (e.g., gross margin back toward the high-50s/low-60s and FCF/share inflecting) by the stated year; if it slips, the thesis-bear is confirmed. This is the whole capstone in miniature: numbers → range → reverse DCF → a falsifiable, monitorable verdict.

Applied mini-project: THE CAPSTONE (the deliverable) + the institutional rubric

This is not a mini-project; it is the module: the institutional-grade thesis package that half-satisfies the M11 final gate. Everything above exists to prepare you to produce it. Budget ~30 of the module's 40 hours here, across the ten-day plan (§4.4).

The task. Select one US company from the §4.2 approved list (or the Form B set in §11) that you have never studied, confirm the integrity rule honestly (no prior teardown, no bull/bear note read), and produce the full nine-component thesis package (§4.3) to the institutional standard (§4.1), unaided and with no AI, sourced only from primary filings (EDGAR: 10-Ks, DEF 14A, transcripts), the company's investor materials, one competitor's materials, one bear note, and your reusable artifacts. Stamp the price and data dates on the cover. Then self-review it in three passes (§4.5) and grade it against the rubric below before declaring it done.

The institutional rubric (printable; score each component 0/1/2 against the anchor; maximum 36).

The pass bar (institutional-grade). ≥ 30/36, with no component scored 0, and the five hard gates (criteria 2, 7, 13, 14, 15) each ≥ 1. A package clearing this bar is what "institutional-grade" means in this program: an integrated, sourced, falsifiable, self-attacked argument ending in a decision. What the tiers mean in practice: ~30–32 is a pass: competent and complete, but with soft spots to strengthen (typically communication craft, or a thin scuttlebutt/steelman); ~33–36 is unambiguously institutional-grade, the standard the worked walkthrough (§6, 35/36) illustrates, and the standard M10.04's final audit expects across both capstones. Below 30, or any hard gate at 0: not yet institutional. Diagnose the weak components (the rubric total is a map, not a verdict), strengthen exactly those, and, if the failure is structural (e.g., no variant perception, an un-steelmanned bear), rework those sections on the same company before re-scoring. This capstone is not re-sat on a fresh company for a soft miss. Unlike a timed teardown, a deep dive is reworked, because rework builds the skill and a new target only rebuilds the hope.

Submission = the package + your own rubric score + the calibration entry. File it in the permanent company note and the decision journal; it becomes the first exhibit of the public track record you build in M10.04 and the raw material M10.03 teaches you to present.

Case Lab: run case XL-10.1 (The Capex-Trough Compounder, synthetic) in the app's Cases tab for this module: a guided, auto-graded dry run of the capstone's valuation core on a synthetic US integrated-device maker mid-build: you rebuild the base-case DCF from the FCFF path, construct the two-way sensitivity surface (§6.11), assemble the bull/bear bridge that attributes the range to each assumption (§6.12), invert the price with a reverse DCF, and deliver the triangulated range, the margin-of-safety price, and a one-sentence variant perception against the key. It is the §6.4 valuation on rails, before you run it unaided on your live company.

Reading & resources

The capstone adds almost no new reading. Its whole job is to apply what you have already read. These are the working references to keep open during the two weeks, plus the primary sources for the candidate list.

• The two program playbooks: playbook-1-2-hour-teardown.md and playbook-2-3-day-deep-dive.md. The deep-dive workbook is the capstone's deliverable structure; print it and fill it to the institutional standard. [Free] [program artifact]
• The reusable checklists and workflows: the valuation workflow, sector KPI cheat-sheets, red-flags / QoE checklist, mental-model & moat checklist, and macro dashboard. Your desk kit; a professional keeps these open forever. [Free] [program artifacts]
• Aswath Damodaran, Narrative and Numbers, plus his free NYU valuation spreadsheets (fcffginzu, the reverse-DCF sheets) and January data library. The discipline behind the capstone's narrative-and-numbers criterion and the engine behind the three-way valuation; pull the live risk-free, ERP, and industry-beta numbers from his site each January. [Book Paid / spreadsheets & data Free] [Intermediate–Advanced]
• Michael Mauboussin (Counterpoint Global): Measuring the Moat, The Base Rate Book, and Expectations Investing (with Rappaport). The moat-in-the-ROIC-series logic (component 3), the base-rate discipline that judges the reverse DCF (component 4), and the expectations-investing spine of the whole variant-perception method. All free as reports. [Free] [Advanced]
• Barbara Minto, The Pyramid Principle. The conclusion-first, MECE structure the one-page thesis and the whole package are graded on (criterion 18). Read the précis now; M10.03 teaches it in full. [Paid] [Intermediate]
• Thorndike, The Outsiders. The capital-allocation benchmark for reading a management's ten-year record (component 5): what disciplined, per-share-value-focused allocation looks like across eight case studies. [Paid] [Intermediate]
• Primary sources for the candidate list (all free — your syllabus for life): SEC EDGAR (10-K Item 1/1A, DEF 14A, 10-Qs, 8-Ks, transcripts via IR pages) for every US name; stockanalysis.com / TIKR / Koyfin for the ten-year panel to cross-check your hand build (never to replace it); the company investor-relations pages for capital-management materials and call transcripts; Damodaran's data for WACC inputs and industry benchmarks; Digi-Key/Mouser, Glassdoor, competitor filings for scuttlebutt channels. No secondary summary and no AI is required or permitted for the deliverable. [Free] [Beginner–Advanced]
• Business Breakdowns and Acquired (podcasts). For calibration only: after you finish your package, find an episode on a similar business and compare your read to a professional's; never before (it would contaminate the never-studied integrity of your own work). [Free] [Beginner]
• Going deeper: Aswath Damodaran's FCFF valuation spreadsheet (fcffginzu) + his "dealing with cyclical and commodity companies" and annual data-update posts (pages.stern.nyu.edu → Spreadsheets/Data; aswathdamodaran.blogspot.com) [Free] [Advanced]. Build the §6.11 sensitivity surface and the §6.12 bridge in a live model: the sheet lets you flex WACC, terminal growth, and normalized margins and watch the per-share value move, and the cyclical-company posts are the discipline behind normalizing FCFF to mid-cycle before you capitalize it. Rebuild the TXN base case in it, then vary one driver at a time.
• Going deeper: Alfred Rappaport & Michael Mauboussin, Expectations Investing (revised edition), the price-implied-expectations and value-driver chapters (Columbia Business School Publishing; free tools at expectationsinvesting.com) [Paid] [Advanced]. This is the formal method under §6.12: convert the reverse DCF's single implied number into a full set of price-implied expectations, then walk the operating value drivers (sales growth, margin, incremental investment) to see which one the market's price is really wagering on. That is the bull/bear bridge done at the level of the underlying business, not just the three summary levers.

The Modern Analyst's Addendum

Everything above teaches this skill from first principles, by hand — that is how you learn it, and the mastery check still tests it that way. This addendum shows how a working analyst amplifies the same skill today. It adds; it never replaces. (R1/R10)

AI-Augment this skill

{
  "skill": "The nine-component institutional thesis package on a US large-cap: the hand-rebuilt ten-year history and incremental ROIC, the industry map, the four-lens moat verdict, the three-way valuation and its range, the DEF 14A incentive read, scuttlebutt, the call audit and steelmanned bear, the one-page thesis, and the pre-mortem dashboard",
  "use": "Read Section 4.1 before this callout: the capstone is explicitly unaided, and no AI drafts, summarises or checks a single line of the package. That constraint is not negotiable and this callout does not soften it. What the callout is for is the work that comes AFTER the capstone is submitted and graded - the second capstone, the tenth, the professional practice this module is an assay for. In that setting: (1) REPRODUCIBILITY HARNESS. Have a coding assistant write the code that pulls the panel's mechanical rows from EDGAR XBRL companyfacts by tag and rebuilds them on demand, so next year's update is a re-run rather than a re-typing. It is writing the plumbing, not forming the judgement. (2) NORMALIZATION LOG as a schema: every choice - the tax rate in NOPAT, what nets off invested capital, whether goodwill is in - recorded as a named field with the filing reference, so a reader months later can regenerate your ROIC rather than trusting it. (3) PROMISE-LEDGER EXTRACTION from eight transcripts, which is mechanical retrieval against a stated claim. (4) The HOSTILE-PM READ of Section 4.5's Pass 2, once your own pass is written down and saved separately, so you can see what a reader without your attachment to the work finds unsupported.",
  "tools": ["Coding assistants — for the EDGAR XBRL companyfacts pull, the panel rebuild and the sensitivity surface as code", "Document/PDF AI — for the promise ledger across eight transcripts and the DEF 14A metric-definition diff year over year", "Chat assistants — Claude, ChatGPT for the hostile-PM read of a finished, already-self-graded package"],
  "prompt": "Write Python that pulls these US-GAAP XBRL facts for CIK <CIK> from the EDGAR companyfacts endpoint for fiscal years <Y1>-<Y2>: Revenues, GrossProfit, OperatingIncomeLoss, NetIncomeLoss, DepreciationDepletionAndAmortization, NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment, WeightedAverageNumberOfDilutedSharesOutstanding, PaymentsOfDividendsCommonStock, PaymentsForRepurchaseOfCommonStock. Return a tidy dataframe with one row per fiscal year and a column recording, per cell, the exact tag, unit and accession number it came from. Do NOT compute NOPAT, invested capital or ROIC - I define those. Flag any year where a tag is missing or where two accessions disagree.",
  "verify": "The single most important verification is the one the XBRL pull makes easy to skip: tags change. A company that reported Revenues for eight years and RevenueFromContractWithCustomerExcludingAssessedTax after ASC 606 will silently produce a broken series, and a restated prior year exists at two accession numbers with two different values - which is why the pull must carry the accession per cell and why you reconcile the oldest year against the printed 10-K page before you trust ten years of it. Every mechanical row still gets spot-checked against the filing: three cells per row, at the two ends and the middle. And nothing in the pull touches the three rows that matter most - NOPAT, invested capital and ROIC are your definitions, and the moat verdict rests on them, so they are hand-built and their normalizations are logged in prose a stranger could follow.",
  "diy": "The gate is unaided and this module's gate is the whole package: you rebuild ten years from the filings by hand, compute incremental ROIC over rolling windows and interpret the lag, build a WACC from scratch, run a DCF, comps and a reverse DCF to a defended range, dissect a proxy, steelman a bear, and write a one-page thesis with a falsifiable variant perception. No tool is in that room, and Section 4.1 means it."
}

Modern Data Analysis

By hand first. You rebuilt ten years from the 10-Ks, logged every normalization, computed incremental ROIC over two windows and reconciled a −2.3% reading against a 50% one, built a WACC, ran three valuation methods to a $120–200 range, and rebuilt the base case to $131.68 a share from stated inputs. All of that is the module and none of it is delegable: §4.1 is explicit that the capstone is unaided, and this addendum does not amend it. What follows is about the afterlife of the artifact you produce: whether it can still be regenerated in eighteen months, by you, from named sources.

Today's workflow. A capstone package is a claim about a company and also an object with a shelf life. Two packages can be equally correct today and differ completely a year later.

• The mechanical rows should regenerate on demand, from named tags. EDGAR's XBRL companyfacts endpoint returns every tagged fact a filer has ever reported, per tag, per period, with the accession number that reported it. A panel row built from OperatingIncomeLoss is a query; a panel row typed off a PDF is a memory.
• The judgement rows should be logged, not automated. NOPAT's tax rate and the invested-capital definition are choices, not facts, and the lens below shows how much of the headline number they move. A normalization log is what makes a choice auditable rather than invisible.
• And the valuation should ship as a function. §6.11 already treats the DCF as a surface. Once it is code, the surface regenerates when the price moves, which is what stops a dated thesis from being quietly re-used at a price it was never written for.

Tools & sources (IN + US). requests and pandas for the XBRL pull and the panel, numpy for the surface, matplotlib for the sensitivity heat map, and plain-text .md plus a version-controlled folder for the normalization log, because the log's value is that it is diffable. US: EDGAR XBRL companyfacts (data.sec.gov/api/xbrl/companyfacts/CIK##########.json) and the frames endpoint for cross-company comparison; the real tags for this panel are Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, GrossProfit, OperatingIncomeLoss, NetIncomeLoss, DepreciationDepletionAndAmortization, NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment, WeightedAverageNumberOfDilutedSharesOutstanding, PaymentsOfDividendsCommonStock, PaymentsForRepurchaseOfCommonStock; EDGAR full-text search for the DEF 14A metric-definition diff; FRED (DGS10 for the risk-free rate, GDP and GDPPOT for the nominal-growth cap the terminal g must respect); Damodaran's implied ERP and industry beta tables at pages.stern.nyu.edu for the WACC build; Ken French for the sector beta cross-check. India (the contrast M10.02 inherits) has no companyfacts equivalent: MCA's XBRL filings are per-document and gated, NSE and BSE publish quarterly results as structured announcements plus PDFs, and screener.in and similar are convenience layers over the same PDFs. The Indian panel is therefore rebuilt from the consolidated annual report and cross-checked against the exchange filing, which is slower and, more importantly, less mechanically reproducible. That is a fact about the asymmetry, stated here so M10.02's promise can be honest rather than aspirational.

# Rebuild §6.11's base case as a function, then audit what regenerates. R3, in-session.
import numpy as np
F, W, G, ND, SH = np.array([2.5, 4.0, 6.0, 7.5, 8.5]), 0.09, 0.035, 5.0, 912e6

def per_share(path=F, w=W, g=G, mult=1.0):
    p = path*mult
    pv = sum(f/(1+w)**(i+1) for i, f in enumerate(p))
    tv = p[-1]*(1+g)/(w-g) / (1+w)**5
    return (pv + tv - ND)*1e9/SH

print(round(per_share(), 2))                                  # 131.68  -> §6.11's "$131.7"
print([round(per_share(mult=m, g=gg, w=ww), 1) for m, gg, ww in
       ((0.8, 0.025, 0.095), (1.0, 0.035, 0.090), (1.2, 0.040, 0.085))])  # [82.1, 131.7, 194.7]

# the reverse DCF is one line, and it is where the verdict actually lives
EV = 178.0
print([(nf, round((W - nf/EV)*100, 2)) for nf in (7.0, 8.5, 8.9, 10.0)])
# [(7.0, 5.07), (8.5, 4.22), (8.9, 4.0), (10.0, 3.38)]  -> the 4% GDP line breaks at $8.9bn

# what does the 13% tax choice and the goodwill choice do to the moat's headline number?
for tax in (0.11, 0.13, 0.15, 0.21):
    print(tax, round(5.6*(1-tax)/28.8*100, 1), round(5.6*(1-tax)/(28.8-4.4)*100, 1))
# 0.11 17.3 20.4 | 0.13 16.9 20.0 | 0.15 16.5 19.5 | 0.21 15.4 18.1

Verify. Every figure in the walkthrough reproduces from its stated inputs. §6.11's base case: explicit-period PV $21.13bn, terminal value $160.0bn on FY29 FCFF of $8.5bn at g = 3.5%, discount factor 0.6499, PV of terminal $104.0bn, EV $125.1bn, equity $120.1bn, and $131.68 a share, the module's "$131.7, rebuilt to the dollar." The 3 × 3 surface returns $96 / $112 / $121 / $113 / $132 / $144 / $130 / $152 / $166, matching every printed cell. §6.12's three cases return $82.1 / $131.7 / $194.7 and the bridge legs +$44 / +$30 / +$38 for a +$113 total (the module prints +$39 for the WACC leg against my $38, a one-dollar rounding difference in the same direction as its own $195-versus-$194.7). §6.1's panel: ROIC of 30.1 / 36.5 / 45.3 / 48.0 / 27.7 / 16.9% for FY15/18/21/22/23/24 against the printed 30 / 36 / 45 / 48 / 28 / 17; FCF of 3.3 / 5.9 / 6.3 / 5.9 / 1.3 / 1.5; FCF per share $3.15 / $5.93 / $6.76 / $6.43 / $1.42 / $1.64. Window A's ROIIC is 50.0% exactly; Window B's is −2.3%, which is the module's "≈ 0%" read the naive way. §6.4's comps: 36.0× trough FY24 EPS of $5.28, and 21.7× / 19.7× on normalized EPS of $8.0bn / $8.8bn net income. The reverse DCF at EV $178bn returns 4.22% implied growth on $8.5bn normalized FCFF.

Quantitative lens

A regeneration audit of this module's own panel: 84% is a query, 16% is the thesis. Classify each of the nineteen rows in §6.1's history by what it would take to rebuild it in eighteen months. Seven rows (36.8%) are a single XBRL tag: revenue, EBIT, net income, CFO, capex, diluted shares, and the dividend-plus-buyback line. Nine rows (47.4%) are arithmetic on tags: the margins, growth, FCF, FCF per share, CFO/EBITDA, FCF/PAT, net debt and net debt/EBITDA. So sixteen of nineteen rows, 84.2%, regenerate mechanically from named sources with no judgement at all. The remaining three rows (15.8%) are analyst choices: NOPAT (which needs a tax rate), invested capital (which needs a definition), and ROIC (which inherits both). And those three are precisely the rows the moat verdict is built on. §6.3's Lens 4 concludes "wide moat" from a ROIC series; §6.1's crux is an incremental-ROIC reading. The reproducible part of the package is not the part the conclusion rests on, which is exactly why §4.1's "every normalization logged" is not clerical tidiness. It is the only thing that makes the load-bearing 16% checkable by anyone, including your future self.

How much do those three rows move on choices the filing does not make for you? FY24 EBIT of $5.6bn and invested capital of $28.8bn are filing facts. The tax rate is not: at 11% the FY24 ROIC is 17.3%, at 13% (the walkthrough's choice) 16.9%, at 15% 16.5%, and at the 21% US statutory rate 15.4%, which is a 1.9-point band from one undocumented decision. The goodwill treatment is not a filing fact either: excluding the $4.4bn of National Semiconductor goodwill from invested capital raises FY24 ROIC from 16.9% to 20.0%, a 3.1-point move, larger than the tax band. Together the two choices span roughly 15.4% to 20.4%. Note what that range does and does not do. It does not flip §6.3's verdict, because every cell clears the ~9% WACC comfortably and the moat test is about the spread over the cost of capital, not the second decimal. It does span the distance between describing a business as good and describing it as elite, which is the distance a one-page thesis lives in. Both facts belong in the package: the verdict is robust to the ambiguity, and the adjective is not.

And the module's central conclusion turns on a number that is a judgement, with a computable break-point. §6.4 concludes that at $190 "the price embeds a full, on-time recovery plus above-GDP growth" and therefore offers no margin of safety. That conclusion runs through the Gordon inversion g = WACC − FCFF/EV, and the FCFF in it is normalized: an analyst estimate of what the business earns once the fabs load, not a reported figure. Walk it: at EV $178bn and a 9% WACC, a normalized FCFF of $7.0bn implies 5.07% perpetual growth, $8.0bn implies 4.51%, the walkthrough's $8.5bn implies 4.22%, $9.0bn implies 3.94%, and $10.0bn implies 3.38%. The verdict "above US nominal GDP of about 4%" therefore holds for every normalized FCFF below $8.9bn and fails above it. The break-even is exactly EV × (WACC − g) = 178 × 0.05 = $8.9bn. So the difference between "the market is paying up toward the bull leg" and "the market is asking for less than the economy" is a $400m difference in an $8.5bn estimate, under 5%. That is not a flaw in the walkthrough, which states its input and shows its work; it is the discipline the reverse DCF is for. Report the break-even input alongside the answer ("my conclusion flips if normalized FCFF is above $8.9bn"), because that single sentence tells a reader what the thesis is actually a bet on, and it is checkable later against what the company reports.

Honest limits, and one of them is about this addendum rather than the module. All the figures above are recomputations of an explicitly illustrative walkthrough: §6's own header states the panel is round approximations modeled on FY24/FY25 scale, so reproducing them proves the arithmetic and the engine, not anything about Texas Instruments, and none of it should be read as a valuation of that company. The regeneration audit is a classification I performed on this particular nineteen-row panel; a bank's panel (NIM, CET1, provision coverage, ROTCE) has a different and generally worse mechanical share, because the tags are sparser and the sector-specific ratios are almost all constructed. So 84% is not a rule, it is a measurement of one specimen, and the useful move is to run the audit on your own panel and see what fraction you would have to retype. XBRL itself is only as reliable as the filer's tagging: tags change across accounting standards, prior years get restated under a new accession, and a company can tag the same economic item differently across a decade, so a pull that does not carry the accession number per cell is reproducible and wrong at the same time. The sensitivity results hold WACC and the explicit path fixed while moving one lever, and §6.12 already warns that the attribution is path-dependent. And the deepest limit is structural: reproducibility is a property of the numbers, and roughly half of the nine components (the scuttlebutt mosaic, the candor verdict, the culture read, the steelmanned bear) are irreducibly unreproducible judgements about which the only honest discipline is to date them, source them, and say what would change them.

Do it in code: pull the mechanical rows by tag with the accession recorded per cell, hand-build and log the three judgement rows, write the DCF as a function so the surface regenerates when the price moves, and report the break-even input beside every headline conclusion. Then check the whole panel's oldest year against the printed 10-K page, because a decade of mechanically-correct wrong numbers is the specific failure this workflow introduces. See G2/QD2.04, G2/CS2.05 and G2/CS2.02.

Where this goes next: galaxy cross-links

• G2 · QD2.04 Reproducible Research & Deployment covers the discipline that turns a thesis package into an artifact that regenerates: pinned inputs, a normalization log, dated outputs, and the test that fails when a source moves under you.
• G2 · CS2.05 APIs, HTTP & JSON does the EDGAR companyfacts and frames endpoints concretely: pagination, rate limits, the required user-agent, and how to carry the accession number through to the cell so a figure stays traceable.
• G2 · DA1.02 Pandas Data Wrangling: reshaping tagged facts into a fiscal-year panel, which is where restatements, changed tags and duplicate accessions do their damage silently.
• G2 · CS2.02 Version Control with Git: the package as a versioned, diffable object, so "what did I believe in March and what changed?" is a command rather than a recollection.
• G3 · CN1.03 The So-What: the one-page thesis as a conclusion-first document, and the discipline of stating the break-even input beside the answer so a reader learns what the thesis is a bet on.

Teach it back & journal

Teach it back (Feynman). In one page, explain to a smart friend who has never invested: "What is the difference between knowing a company well and having a thesis on it?" Use one concrete example (yours, or the TXN walkthrough). Your explainer succeeds if the friend can, afterwards, state in their own words why "it's a great company" is not a reason to buy, what a "variant perception" is, and why an honest analyst sometimes does two weeks of work and concludes "fairly valued — no edge — pass." If you cannot make those three ideas land simply, you do not yet own the thing this module certifies.

Journal reflection. After you finish and self-grade your capstone package, write a journal entry answering: (1) Which component scored lowest, and is that a one-off or my error signature (compare to your M8.05 miss taxonomy)? (2) What did the reverse DCF reveal that I did not expect before running it? Did the market believe something different from what I assumed? (3) What is my honest confidence (as a probability) in the variant perception, the two break-variables that would change my mind, and my re-check date? Then, crucially: (4) if I had to bet real money on this thesis today at the current price, would I? And if not, at what price would I, and is that gap telling me the analysis is incomplete or the price is simply not yet right? File this entry unedited; it is the calibration hook on which reality will grade your reasoning months from now, and the difference, in five years, between an analyst who improved and one who merely accumulated reps.

This module's flashcards and mastery quiz are wired into the app: see the node's Quiz and Reviews.